High expression of TRMT6 is associated with a poor prognosis in CRC patients, and its translational regulation is key for CRC cell proliferation, indirectly suggesting that a preference for AAA/AAG codons may continue to play a role in CRC progression. Here, TRMT6 is linked to colorectal carcinoma.